Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Not applicableStudy completedNCT02427204
What this trial is testing

Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality

Who this might be right for
Hepatitis C Infection
Icahn School of Medicine at Mount Sinai 150
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Large-scale testing (Phase 3)Study completedNCT00308048
What this trial is testing

14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response

Who this might be right for
Hepatitis C Virus Infection
Ullevaal University Hospital 435
Large-scale testing (Phase 3)Study completedNCT00039871
What this trial is testing

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Who this might be right for
HepatitisHepatitis C, ChronicFibrosis+1 more
Merck Sharp & Dohme LLC 2,333
Testing effectiveness (Phase 2)Study completedNCT00088504
What this trial is testing

Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis CHepatitis
Vertex Pharmaceuticals Incorporated 315
Testing effectiveness (Phase 2)Study completedNCT01306617
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C InfectionHepatitis CHepatitis C Virus
AbbVie (prior sponsor, Abbott) 50
Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Post-approval studies (Phase 4)Study completedNCT00275548
What this trial is testing

Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C

Who this might be right for
Liver TransplantHepatitis C
Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Testing effectiveness (Phase 2)Study completedNCT00227435
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT02673489
What this trial is testing

Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT04042740
What this trial is testing

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Who this might be right for
Hepatitis C InfectionHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 45
Large-scale testing (Phase 3)Study completedNCT01903278
What this trial is testing

Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Beijing Kawin Technology Share-Holding Co., Ltd. 719
Early research (Phase 1)Study completedNCT01591668
What this trial is testing

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Gilead Sciences 51
Large-scale testing (Phase 3)Ended earlyNCT03099135
What this trial is testing

A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C
Janssen Research & Development, LLC 24
Not applicableStudy completedNCT01464008
What this trial is testing

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Beijing Ditan Hospital 297
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Early research (Phase 1)Study completedNCT00591214
What this trial is testing

Safety and PK Study of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Next Page